Mintz Steven's Form 4 filing
Serina Therapeutics, Inc. (SER) · filed May 23, 2024
- Accession no.
- 0001493152-24-021176
- Filed
- May 23, 2024
- Trade date
- May 17-21, 2024
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market purchases total $120.8K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mintz StevenCIK 0002008741 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | Common Stock | PPurchaseAcquired | +554 | $8.50 | +$4,709 | 554 | Indirect | |
| May 20, 2024 | Common Stock | PPurchaseAcquired | +195 | $9.48 | +$1,848.6 | 749 | Indirect | |
| May 21, 2024 | Common Stock | PPurchaseAcquired | +6,651 | $10.00 | +$66,510 | 7,400 | Indirect | |
| May 21, 2024 | Common Stock | PPurchaseAcquired | +2,500 | $9.75 | +$24,375 | 9,900 | Indirect | |
| May 20, 2024 | Common Stock | PPurchaseAcquired | +1,240 | $9.44 | +$11,705.6 | 1,240 | Indirect | |
| May 20, 2024 | Common Stock | PPurchaseAcquired | +1,240 | $9.42 | +$11,680.8 | 1,240 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.